These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice. Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824 [TBL] [Abstract][Full Text] [Related]
5. Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity. Fam BC; Morris MJ; Hansen MJ; Kebede M; Andrikopoulos S; Proietto J; Thorburn AW Diabetes Obes Metab; 2007 Nov; 9(6):840-52. PubMed ID: 17924866 [TBL] [Abstract][Full Text] [Related]
6. Raw vegetable food containing high cyclo (his-pro) improved insulin sensitivity and body weight control. Song MK; Rosenthal MJ; Song AM; Yang H; Ao Y; Yamaguchi DT Metabolism; 2005 Nov; 54(11):1480-9. PubMed ID: 16253637 [TBL] [Abstract][Full Text] [Related]
7. Effects of PPARgamma and PPARalpha agonists on serum leptin levels in diet-induced obese rats. Törüner F; Akbay E; Cakir N; Sancak B; Elbeg S; Taneri F; Aktürk M; Karakoç A; Ayvaz G; Arslan M Horm Metab Res; 2004 Apr; 36(4):226-30. PubMed ID: 15114521 [TBL] [Abstract][Full Text] [Related]
8. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice. Tomas E; Wood JA; Stanojevic V; Habener JF Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160 [TBL] [Abstract][Full Text] [Related]
9. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice. Kowalski TJ; Spar BD; Weig B; Farley C; Cook J; Ghibaudi L; Fried S; O'Neill K; Del Vecchio RA; McBriar M; Guzik H; Clader J; Hawes BE; Hwa J Eur J Pharmacol; 2006 Mar; 535(1-3):182-91. PubMed ID: 16540104 [TBL] [Abstract][Full Text] [Related]
10. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures. Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527 [TBL] [Abstract][Full Text] [Related]
11. Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine. Mashiko S; Ishihara A; Iwaasa H; Moriya R; Kitazawa H; Mitobe Y; Ito J; Gomori A; Matsushita H; Takahashi T; MacNeil DJ; Van der Ploeg LH; Fukami T; Kanatani A Obesity (Silver Spring); 2008 Jul; 16(7):1510-5. PubMed ID: 18421274 [TBL] [Abstract][Full Text] [Related]
12. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats. Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194 [TBL] [Abstract][Full Text] [Related]
13. Daily oral oleoyl-estrone gavage induces a dose-dependent loss of fat in Wistar rats. del Mar Grasa M; Cabot C; Esteve M; Yubero P; Masanés RM; Blay MT; Vilà R; López-Martí J; Fernández-López JA; Remesar X; Alemany M Obes Res; 2001 Mar; 9(3):202-9. PubMed ID: 11323446 [TBL] [Abstract][Full Text] [Related]
15. Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides. Malmlöf K; Golozoubova V; Peschke B; Wulff BS; Refsgaard HH; Johansen PB; Cremers T; Rimvall K Obesity (Silver Spring); 2006 Dec; 14(12):2154-62. PubMed ID: 17189541 [TBL] [Abstract][Full Text] [Related]
16. Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats. Picard F; Deshaies Y; Lalonde J; Samson P; Richard D Obes Res; 2000 Dec; 8(9):656-63. PubMed ID: 11225714 [TBL] [Abstract][Full Text] [Related]
17. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats. Larsen PJ; Vrang N; Petersen PC; Kristensen P Obes Res; 2000 Nov; 8(8):590-6. PubMed ID: 11156435 [TBL] [Abstract][Full Text] [Related]
18. The novel antiobesic HMR1426 reduces food intake without affecting energy expenditure in rats. Ortmann S; Kampe J; Gossel M; Bickel M; Geisen K; Jähne G; Lang HJ; Klaus S Obes Res; 2004 Aug; 12(8):1290-7. PubMed ID: 15340112 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor gamma agonist in the spontaneously hypertensive obese rat model of metabolic syndrome X. Velliquette RA; Friedman JE; Shao J; Zhang BB; Ernsberger P J Pharmacol Exp Ther; 2005 Jul; 314(1):422-30. PubMed ID: 15833894 [TBL] [Abstract][Full Text] [Related]
20. Weight gain model in prepubertal rats: prediction and phenotyping of obesity-prone animals at normal body weight. Leibowitz KL; Chang GQ; Pamy PS; Hill JO; Gayles EC; Leibowitz SF Int J Obes (Lond); 2007 Aug; 31(8):1210-21. PubMed ID: 17471301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]